- $585.43m
- $554.44m
- $109.90m
- 90
- 35
- 29
- 50
Annual income statement for OTC Markets, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PRESS | PRESS | PRESS | PRESS | PRESS |
| Standards: | — | — | — | — | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 62.8 | 71.2 | 103 | 105 | 110 |
| Cost of Revenue | |||||
| Gross Profit | 59.6 | 65.4 | 90.6 | 96.2 | 101 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Total Operating Expenses | 45 | 49.8 | 64.9 | 68.3 | 77.3 |
| Operating Profit | 17.9 | 21.4 | 38 | 36.8 | 32.6 |
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 18 | 21.4 | 38 | 37 | 33.5 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 14.9 | 18.3 | 30.5 | 30.8 | 27.7 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 14.9 | 18.3 | 30.5 | 30.8 | 27.7 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 14.9 | 18.3 | 30.5 | 30.8 | 27.7 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 1.28 | 1.57 | 2.58 | 2.59 | 2.33 |
| Dividends per Share | |||||
| Special Dividends per Share |